The effects of vagal nerve stimulation in focal cerebral ischemia and reperfusion model

Turkish Neurosurgery

Volumn 23, Issue 4, 2013, Pages 451-457

  Ekici, Fatih ^a   Karson, Ayse ^b   Dillioglugil, Meltem Ozden ^b   Gurol, Gonul ^c   Kir, Hale Maral ^b   Ates, Nurbay ^a  

^a YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c SAKARYA UNIVERSITY   (Turkey)

Author keywords

Focal cerebral ischemia; GSH; MDA; SOD; TTC; VNS

Indexed keywords

COLORING AGENT; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TETRAZOLIUM; TRIPHENYLTETRAZOLIUM;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL ARTERY DISEASE; ELECTRODE IMPLANT; MALE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REPERFUSION INJURY; VAGUS NERVE STIMULATION; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CEREBRAL INFARCTION; COLORING AGENTS; ELECTRODES, IMPLANTED; GLUTATHIONE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; TETRAZOLIUM SALTS; VAGUS NERVE STIMULATION;

EID: 84881508108     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: 10.5137/1019-5149.JTN.7114-12.1     Document Type: Article

References (54)

1. Adibhatla RM, JF: Lipid oxidation and peroxidation in CNS health and disease: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12:125-169, 2010
2. Aguiar CC, Almeida AB, Araújo PV, de Abreu RN, Chaves EM, do Vale OC, Macêdo DS, Woods DJ, Fonteles MM,: Oxidative stress and epilepsy: Literature review. Oxid Med Cell Longev 2012:795259, 2012
3. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT: Post-ischemic brain damage: Pathophysiology and role of inflammatory mediators. FEBS J 276:13-26, 2009
4. Andersen JK: Oxidative stress in neurodegeneration: Cause or consequence. Nat Med 10:S18-25, 2004
5. Ay I, Lu J, Ay H, Gregory Sorensen A: Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia. Neurosci Lett 14:147-151, 2009
6. Ay I, Sorensen AG, Ay H: Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia: An unlikely role for cerebral blood flow. Brain Res 25:110-115, 2011
7. Badruddin A, Taqi MA, Abraham MG, Dani D, Zaidat OO: Neurocritical care of a reperfused brain. Curr Neurol Neurosci Rep 11:104-110, 2011
8. Banerjee S: Effects of vagus nerve stimulation on hippocampal and cortical amino acid levels following lateral fluid percussion injury in rats: A microdialysis study (thesis), Southern Illinois Universty at Carbondale, 2006: 1-136
9. Bansal V, Ryu SY, Lopez N, Allexan S, Krzyzaniak M, Eliceiri B, Baird A, Coimbra R: Vagal stimulation modulates inflammation through a ghrelin mediated mechanism in traumatic brain injury. Inflammation 35:214-220, 2012
10. Ben-Menachem E, Hamberger A, Hedner T, Hammond EJ, Uthman BM, Slater J, Treig T, Stefan H, Ramsay RE, Wernicke JF, et al: Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res 20:221-227, 1995
11. Bernik TR, Friedman SG, Ochani M, Di Raimo R, Susarla S, Czura CJ, Tracey KJ: Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 36:1231-1236, 2002
12. Brouns R, De Deyn PP: The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg 111:483-495, 2009
13. Buege JA, Aust SD: Microsomal lipid peroxidation. Meth Enzymol 52:302-310, 1978
14. Calvillo L, Vanoli E, Andreoli E, Besana A, Omodeo E, Gnecchi M, Zerbi P, Vago G, Busca G, Schwartz PJ: Vagal stimulation, through its nicotinic action, limits infarct size and the inflammatory response to myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 58:500-507, 2011
15. Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P, Goeders CE, Chan PH: Oxidative stress in ischemic brain damage: Mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 14(8):1505-1517, 2011
16. Chong ZZ, Kang JQ, Maiese K: Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. Antioxid Redox Signal 6:277-287, 2004
17. Costello DJ, Delanty N: Oxidative injury in epilepsy: Potential for antioxidant therapy. Expert Rev Neurother 4:541-553, 2004
18. Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science 29(262):689-695, 1993
19. Crack PJ, Taylor JM: Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 38:1433-1444, 2005
20. Cunningham JT, Mifflin SW, Gould GG, Frazer A: Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. Neuropsychopharmacology 33:1884-1895, 2008
21. Ellman GL: Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77, 1959
22. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, Sarinella F, Frattola L, De Simoni MG: Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 19(9):1004-1009, 1999
23. George MS, Nahas Z, Bohning DE, Lomarev M, Denslow S, Osenbach R, Ballenger JC: Vagus nerve stimulation: A new form of therapeutic brain stimulation. CNS Spectr 5:43-52, 2000
24. Green AR, Shuaib A: Therapeutic strategies for the treatment of stroke. Drug Discov Today 11:681-693, 2006
25. Gupta YK, Chauhan A: Potential of immunosuppressive agents in cerebral ischaemia. Indian J Med Res 133:15-26, 2011
26. Henry TR, Votaw JR, Pennell PB, Epstein CM, Bakay RAE, Faber TL, Grafton ST, Hoffman JM: Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology 52:1166-1173, 1999
27. Hiraki T, Baker W, Greenberg JH: Effect of vagus nerve stimulation during transient focal cerebral ischemia on chronic outcome in rats. J Neurosci Res 90:887-894, 2012
28. Khan M, Sakakima H, Dhammu TS, Shunmugavel A, Im YB, Gilg AG, Singh AK, Singh I: S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats. J Neuroinflammation 6(8):78, 2011
29. Kong SS, Liu JJ, Hwang TC, Yu XJ, Lu Y, Zang WJ: Tumour necrosis factor-a and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats. Clin Exp Pharmacol Physiol 38:300-306, 2011
30. Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer HC, Bauer H: Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxid Redox Signal 15:1305-1323, 2011
31. Leker RR, Shohami E: Cerebral ischemia and traumadifferent etiologies yet similar mechanisms: Neuroprotective opportunities. Brain Res Rev 39:55-73, 2002
32. Longa EL, Weinstein PR, Carlson S, Commins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91, 1989
33. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the phenol reagent. J Biol Chem 193: 265-275, 1951
34. Majoie HJ, Rijkers K, Berfelo MW, Hulsman JA, Myint A, Schwarz M, Vles JS: Vagus nerve stimulation in refractory epilepsy: Effects on pro- and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation 18:52-56, 2011
35. Margaill I, Plotkine M, Lerouet D: Antioxidant strategies in the treatment of stroke. Free Radic Biol Med 39:429-443, 2005
36. Marrosu F, Serra A, Maleci A, Puligheddu M, Biggio G, Piga M: Correlation between GABAA receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy. Epilepsy Res 55:59-70, 2003
37. Masada T, Itano T, Fujisawa M, Miyamoto O, M Tokuda M, Matsui H, et al.: Protective effect of vagus nerve stimulation on forebrain ischemia in gerbil hippocampus. Neuroreport 7:446-448, 1996
38. Miyamoto O, Pang J, Sumitani K, Negi T, Hayashida Y, Ý Tano T: Mecanisms of the antiischemic effect of vagus nerve stimulation in the gerbil hippocampus. Neuroreport 14: 1971-1974, 2003
39. Neese SL, Sherill LK, Tan AA, Roosevelt RW, Browning RA, Smith DC, Duke A, Clough RW: Vagus nerve stimulation may protect GABAergic neurons following traumatic brain injury in rats: An immunocytochemical study. Brain Res 1128(1):157-163, 2007
40. Offer T, Russo A, Samuni A: The pro-oxidative activity of SOD and nitroxide SOD mimics. FASEB J 14(9):1215-1223, 2000
41. Pantoni L, Sarti C, Inzitari D: Cytokines and cell adhesion molecules in cerebral ischemia: Experimental bases and therapeutic perspectives. Arterioscler Thromb Vasc Biol 18(4):503-513, 1998
42. Rizvi SJ, Donovan M, Giacobbe P, Placenza F, Rotzinger S, Kennedy SH: Neurostimulation therapies for treatment resistant depression: A focus on vagus nerve stimulation and deep brain stimulation. Int Rev Psychiatry 23:424-436, 2011
43. Sahin D, Ilbay G, Imal M, Bozdogan O, Ates N: Vagus nerve stimulation suppresses generalized seizure activity and seizure-triggered postictal cardiac rhythm changes in rats. Physiol Res 58:345-350, 2009
44. Sahota P, Savitz SI: Investigational therapies for ischemic stroke: Neuroprotection and neurorecovery. Neurotherapeutics 8:434-451, 2011
45. Saito A, Maier CM, Narasimhan P, Nishi T, Song YS, Yu F, Liu J, Lee YS, Nito C, Kamada H, Dodd RL, Hsieh LB, Hassid B, Kim EE, González M, Chan PH: Oxidative stress and neuronal death/ survival signaling in cerebral ischemia. Mol Neurobiol 31: 105-116, 2005
46. Schmidley JW: Free radicals in central nervous system ischemia. Stroke 21:1086-1090, 1990
47. Sun Y, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 34:497-500, 1988
48. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsô C, Jensen C, Ekholm S, Tarkowski A: Early intrathecal production of interleukin-6 predicts the volume of brain lesion in stroke. Stroke 26:1393-1398, 1995
49. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsô C, Jensen C, Ekholm S, Tarkowski A: Intrathecal release of pro- and antiinflammatory cytokines during stroke. Clin Exp Immunol 110: 492-499, 1997
50. van Westerloo DJ, Giebelen IA, Meijers JC, Daalhuisen J, de Vos AF, Levi M, van der Poll T: Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost 4:1997-2002, 2006
51. Zádori D, Klivényi P, Szalárdy L, Fülöp F, Toldi J, Vécsei L: Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders. J Neurol Sci 322(1-2):187-191, 2012
52. Zaleska MM, Mercado ML, Chavez J, Feuerstein GZ, Pangalos MN, Wood A: The development of stroke therapeutics: Promising mechanisms and translational challenges. Neuropharmacology 56:329-341, 2009
53. Zamponi N, Petrelli C, Passamonti C, Moavero R, Curatolo P: Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. Pediatr Neurol 43:29-34, 2010
54. Zhong P, Pang SF, Cheung RTF: Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 32:168-172, 2002